RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.28
+0.52 (7.69%)
At close: Apr 8, 2026, 4:00 PM EDT
7.32
+0.04 (0.55%)
After-hours: Apr 8, 2026, 7:29 PM EDT
RxSight Stock Forecast
Stock Price Forecast
The 9 analysts that cover RxSight stock have a consensus rating of "Hold" and an average price target of $9.78, which forecasts a 34.34% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $13.
Price Target: $9.78 (+34.34%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 9, 2026.
Analyst Ratings
The average analyst rating for RxSight stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 8 | 8 | 7 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +23.63% | Mar 9, 2026 |
| UBS | UBS | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +23.63% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +37.36% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +78.57% | Feb 26, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +51.10% | Jan 20, 2026 |
Financial Forecast
Revenue This Year
131.78M
from 134.48M
Decreased by -2.01%
Revenue Next Year
144.84M
from 131.78M
Increased by 9.91%
EPS This Year
-1.27
from -0.95
EPS Next Year
-1.05
from -1.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 137.7M | 157.8M | |
| Avg | 131.8M | 144.8M | |
| Low | 125.1M | 133.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.4% | 19.8% | |
| Avg | -2.0% | 9.9% | |
| Low | -7.0% | 1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.95 | -0.62 | |
| Avg | -1.27 | -1.05 | |
| Low | -1.39 | -1.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.